SCHEDULE 13G/A

Statement of Beneficial Ownership

Adaptimmune Therapeutics PLC Filed 2024-12-05 Acc 0000902664-24-006837

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-01-08 SCHEDULE 13G/A Statement of Beneficial Ownership
2024-12-05 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)